SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 30th, 2020 • Kannalife Inc • Pharmaceutical preparations • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 19, 2020, by and between KANNALIFE, INC., a Delaware corporation, with headquarters located at 3805 Old Easton Road, Doylestown, PA 18902 (the “Company”), and ___________, with its address at ______________ (the “Buyer”).
COMMON STOCK PURCHASE WARRANT (WARRANT __) KANNALIFE, INC.Common Stock Purchase • June 30th, 2020 • Kannalife Inc • Pharmaceutical preparations • Nevada
This COMMON STOCK PURCHASE WARRANT (WARRANT A) (the “Warrant”) certifies that, for value received (in connection with the issuance of the $150,000.00 convertible promissory note to the Holder (as defined below) of even date) (the “Note”), _____________ (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Kannalife, Inc., a Delaware corporation (the “Company”), up to 115,385 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated June 19, 2020, by and among the Company and the Holder (the “Purchase Agreement
KANNALIFE, INC.Kannalife Inc • June 30th, 2020 • Pharmaceutical preparations
